Severe occupational asthma: insights from a multicenter European cohort
File(s)INPRACTICE-D-18-01040-R1-Text-UNMARKED.docx (191.63 KB)
Accepted version
Author(s)
Type
Journal Article
Abstract
BACKGROUND: Although sensitizer-induced occupational asthma (OA) accounts for an appreciable fraction of adult asthma, the severity of OA has received little attention. OBJECTIVE: The aim of this study was to characterize the burden and determinants of severe OA in a large multicenter cohort of subjects with OA. METHODS: This retrospective study included 997 subjects with OA ascertained by a positive specific inhalation challenge completed in 20 tertiary centers in 11 European countries during the period 2006 to 2015. Severe asthma was defined by a high level of treatment and any 1 of the following criteria: (1) daily need for a reliever medication, (2) 2 or more severe exacerbations in the previous year, or (3) airflow obstruction. RESULTS: Overall, 162 (16.2%; 95% CI, 14.0%-18.7%) subjects were classified as having severe OA. Multivariable logistic regression analysis revealed that severe OA was associated with persistent (vs reduced) exposure to the causal agent at work (odds ratio [OR], 2.78; 95% CI, 1.50-5.60); a longer duration of the disease (OR, 1.04; 95% CI, 1.00-1.07); a low level of education (OR, 2.69; 95% CI, 1.73-4.18); childhood asthma (OR, 2.92; 95% CI, 1.13-7.36); and sputum production (OR, 2.86; 95% CI, 1.87-4.38). In subjects removed from exposure, severe OA was associated only with sputum production (OR, 3.68; 95% CI, 1.87-7.40); a low education level (OR, 3.41; 95% CI, 1.72-6.80); and obesity (OR, 1.98; 95% CI, 0.97-3.97). CONCLUSIONS: This study indicates that a substantial proportion of subjects with OA experience severe asthma and identifies potentially modifiable risk factors for severe OA that should be targeted to reduce the adverse impacts of the disease.
Date Issued
2019-09
Date Acceptance
2019-03-08
Citation
Journal of Allergy and Clinical Immunology: In Practice, 2019, 7 (7), pp.2309-2318.e4
ISSN
2213-2198
Publisher
Elsevier
Start Page
2309
End Page
2318.e4
Journal / Book Title
Journal of Allergy and Clinical Immunology: In Practice
Volume
7
Issue
7
Copyright Statement
© 2019 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence http://creativecommons.org/licenses/by-nc-nd/4.0/
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/30914232
PII: S2213-2198(19)30281-8
Subjects
Airflow obstruction
Asthma control
Asthma exacerbations
Occupational asthma
Severe asthma
Publication Status
Published
Coverage Spatial
United States
Date Publish Online
2019-03-23